Showing results (91-100 of 524) with videos related to
Sort By:
Pageof 53
Therapeutic Advances in Respiratory Disease|January 7, 2009
Surfactant protein D: a lung specific biomarker in COPD?Don D Sin, Payam S Pahlavan, S F Paul ManAmerican Journal of Respiratory and Critical Care Medicine|May 31, 2014
Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1Harvey O Coxson, Jonathon Leipsic, Grace Parraga, et al.The Canadian Journal of Cardiology|August 21, 2012
Vascular risk in chronic obstructive pulmonary disease: role of inflammation and other mediatorsS F Paul Man, Stephan Van Eeden, Don D SinThe European Respiratory Journal|July 29, 2017
Excess economic burden of comorbidities in COPD: a 15-year population-based studyWenjia Chen, J Mark FitzGerald, Don D Sin, et al.Archives of Internal Medicine|July 2, 2002
Obesity is a risk factor for dyspnea but not for airflow obstructionDon D Sin, Richard L Jones, S F Paul ManPlos One|July 20, 2016
A Systematic Review of Diagnostic Biomarkers of COPD ExacerbationYu-Wei Roy Chen, Janice M Leung, Don D SinThe European Respiratory Journal|January 26, 2019
Introduction to precision medicine in COPDJanice M Leung, Ma'en Obeidat, Mohsen Sadatsafavi, et al.Frontiers in Cardiovascular Medicine|July 12, 2019
Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseLiliana Crisan, Nathan Wong, Don D Sin, et al.Thorax|November 27, 2021
Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary diseaseSafa Ahmadian, Don D Sin, Larry Lynd, et al.BMC Pulmonary Medicine|October 10, 2007
Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot studyDon D Sin, Rochelle Leung, Wen Q Gan, et al.Pageof 53